logo
Select company
Select metric
-3.54%Operating Cash Flow Margin
VS
Market
24
Sector
57
Industry
83
History
84
$ 1.86Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -2.19M-3.54%$ 61.95M
3/31/2025$ -572K-0.96%$ 59.76M
12/31/2024$ 8.67M16.24%$ 53.4M
9/30/2024$ 8.28M18.13%$ 45.67M
6/30/2024$ -2.71M-7.13%$ 38.05M
3/31/2024$ 5.87M9.84%$ 59.65M
12/31/2023$ -1.32M-2.01%$ 65.49M
9/30/2023$ -7.52M-11.83%$ 63.63M
6/30/2023$ -9.84M-14.59%$ 67.46M
3/31/2023$ -22.17M-53.89%$ 41.14M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -36.37%.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average OCF % has been -21.72%.
  • The median OCF % for PROTALIX BIOTHERAPEUTICS INC during this period was -20.22%
  • PROTALIX BIOTHERAPEUTICS INC reached its highest OCF % over the past 5 years at 18.13%.
  • The lowest OCF % recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe -57.76%

PROTALIX BIOTHERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
CSBR : CHAMPIONS ONCOLOGY INC 13.49%THTX : THERATECHNOLOGIES INC 8.34%BDTX : BLACK DIAMOND THERAPEUTICS INC 25.53%SPRO : SPERO THERAPEUTICS INC -66.56%ENTA : ENANTA PHARMACEUTICALS INC -35.77%CELU : CELULARITY INC -5.7%IVVD : INVIVYD INC -244.77%DOMH : DOMINARI HOLDINGS INC -13.35%SGMO : SANGAMO THERAPEUTICS INC -43.94%ALEC : ALECTOR INC -265.74%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -22.24M ] / Revenues [ $ 61.16M ]
(=) OCF % [ -36.37% ]

PLX - Operating Cash Flow Margin, Last 5 years

-57.76%

Minimum

Sep 30, 2022

18.13%

Maximum

Sep 30, 2024

-21.72%

Average

-20.22%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%